Ching Hua Hsiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ching Hua Hsiao has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Jia Shing Chen
I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan
4 shared publicationsYu Ming Shiao
Department of Bioscience Technology, Chung Yuan Christian University, Taiwan
4 shared publicationsJu Chin Tsauer
Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, Taiwan
3 shared publicationsWei Shin Chou
Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, Taiwan
3 shared publicationsYi Fen Chang
Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, Taiwan
3 shared publicationsChen-Te Chou
Department of Biomedical Imaging and Radiological Science, National Yang-Ming Medical University, Taipei, Taiwan; Department of Medical Imaging, Changhua Christian Hospital, Changhua, Chinese Taipei
1 shared publication
Latest Publications
- Open Access
- 23 June 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (13) , 3624
Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies
Background: To assess the value of chromosomal microarray analysis (CMA) during the prenatal diagnosis of high-risk pregnancies. Methods: Between January 2016 and November 2021, we included 178 chorionic villi and 859 amniocentesis samples from consecutive cases at a multiple tertiary hospital. Each of these high-risk singleton pregnancies had at least one of the following indications: (1) advanced maternal age (AMA; ≥35 years; 546, 52.7%); (2) fetal structural abnormality on ultrasound (197, 19.0%); (3) high-risk first- or second-trimester Down syndrome screen (189, 18.2%), including increased nuchal translucency (≥3.5 mm; 90, 8.7%); or (4) previous pregnancy, child, or family history (105, 10.1%) affected by chromosomal abnormality or genetic disorder. Both G-banding karyotype analysis and CMA were performed. DNA was extracted directly and examined with oligonucleotide array-based comparative genomic hybridization. Results: Aneuploidies were detected by both G-banding karyotyping and CMA in 42/1037 (4.05%) cases. Among the 979 cases with normal karyotypes, 110 (10.6%) cases had copy number variants (CNVs) in CMA, including 30 (2.9%) cases with reported pathogenic and likely pathogenic CNVs ≥ 400 kb, 37 (3.6%) with nonreported VOUS, benign, or likely benign CNVs ≥ 400 kb, and 43 (4.1%) with nonreported CNVs < 400 kb. Of the 58 (5.6%) cases with aneuploidy rearrangements, 42 (4.1%) were diagnosed by both G-banding karyotyping and CMA; four inversions, six balanced translocations, and six low mosaic rates were not detected with CMA. Conclusions: CMA is an effective first step for the prenatal diagnosis of high-risk pregnancies with fetal structural anomalies found in ultrasonography or upon positive findings.
- 23 June 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (13) , 3624
Open AccessPrenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies
Background: To assess the value of chromosomal microarray analysis (CMA) during the prenatal diagnosis of high-risk pregnancies. Methods: Between January 2016 and November 2021, we included 178 chorionic villi and 859 amniocentesis samples from consecutive cases at a multiple tertiary hospital. Each of these high-risk singleton pregnancies had at least one of the following indications: (1) advanced maternal age (AMA; ≥35 years; 546, 52.7%); (2) fetal structural abnormality on ultrasound (197, 19.0%); (3) high-risk first- or second-trimester Down syndrome screen (189, 18.2%), including increased nuchal translucency (≥3.5 mm; 90, 8.7%); or (4) previous pregnancy, child, or family history (105, 10.1%) affected by chromosomal abnormality or genetic disorder. Both G-banding karyotype analysis and CMA were performed. DNA was extracted directly and examined with oligonucleotide array-based comparative genomic hybridization. Results: Aneuploidies were detected by both G-banding karyotyping and CMA in 42/1037 (4.05%) cases. Among the 979 cases with normal karyotypes, 110 (10.6%) cases had copy number variants (CNVs) in CMA, including 30 (2.9%) cases with reported pathogenic and likely pathogenic CNVs ≥ 400 kb, 37 (3.6%) with nonreported VOUS, benign, or likely benign CNVs ≥ 400 kb, and 43 (4.1%) with nonreported CNVs < 400 kb. Of the 58 (5.6%) cases with aneuploidy rearrangements, 42 (4.1%) were diagnosed by both G-banding karyotyping and CMA; four inversions, six balanced translocations, and six low mosaic rates were not detected with CMA. Conclusions: CMA is an effective first step for the prenatal diagnosis of high-risk pregnancies with fetal structural anomalies found in ultrasonography or upon positive findings.
- Open Access
- 17 May 2022
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 61 (3) , 517-520
Novel prenatally diagnosed compound heterozygous POMT2 variants in fetal congenital primary aqueduct stenosis
- 17 May 2022
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 61 (3) , 517-520
Open AccessNovel prenatally diagnosed compound heterozygous POMT2 variants in fetal congenital primary aqueduct stenosis
- Open Access
- 17 May 2022
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 61 (3) , 510-513
Novel prenatally diagnosed compound heterozygous PXDN variants in fetal congenital primary aphakia and blepharophimosis
- 17 May 2022
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 61 (3) , 510-513
Open AccessNovel prenatally diagnosed compound heterozygous PXDN variants in fetal congenital primary aphakia and blepharophimosis
- Open Access
- 17 May 2022
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 61 (3) , 514-516
Prenatally diagnosed microdeletion in the TCOF1 gene in fetal congenital primary Treacher Collins Syndrome
- 17 May 2022
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 61 (3) , 514-516
Open AccessPrenatally diagnosed microdeletion in the TCOF1 gene in fetal congenital primary Treacher Collins Syndrome
- Open Access
- 17 May 2022
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 61 (3) , 501-503
Prenatal diagnosis of de novo int22h1/int22h2-mediated Xq28 duplication syndrome involving RAB39B following a previous ambiguous genitalia pregnancy
- 17 May 2022
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 61 (3) , 501-503
Open AccessPrenatal diagnosis of de novo int22h1/int22h2-mediated Xq28 duplication syndrome involving RAB39B following a previous ambiguous genitalia pregnancy
- Open Access
- 9 January 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-8
The impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study
Background: The purpose of this study is to evaluate the impact of prenatal screening tests on prenatal diagnosis in Taiwan’s 14 years from 2006 to 2019. Methods: The prenatal screening methods evolved from the second-trimester serum screening to combined first-trimester screening (cFTS) and then followed by the non-invasive cell-free DNA prenatal test (NIPT). The data used by the Department of Statistics, the Ministry of Health and Welfare and Department of Household Registration, Ministry of the Interior public website. Results: This regional registry-based cohort retrospective study examined a total of 2,775,792 births from January 2006 to December 2019. The proportion of advanced maternal age (AMA) pregnancies increased from 11.63% in 2006 to 30.94% in 2019. Overall, invasive diagnostic testing was used in 87.22% of AMA pregnancies. The prenatal detection rate of trisomy 21 and 18 increased from 74.1% and 83.3% in 2006 to 96.9% and 98.8% in 2019, respectively. Conclusion: During the second-trimester and cFTS periods, the percentage of AMA pregnancies increased every year and the number of invasive procedures also accompany with increased percentage of AMA. However, during the period that NIPT were implemented, the percentage of invasive procedures decreased.
- 9 January 2022
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 22 (1) , 1-8
Open AccessThe impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study
Background: The purpose of this study is to evaluate the impact of prenatal screening tests on prenatal diagnosis in Taiwan’s 14 years from 2006 to 2019. Methods: The prenatal screening methods evolved from the second-trimester serum screening to combined first-trimester screening (cFTS) and then followed by the non-invasive cell-free DNA prenatal test (NIPT). The data used by the Department of Statistics, the Ministry of Health and Welfare and Department of Household Registration, Ministry of the Interior public website. Results: This regional registry-based cohort retrospective study examined a total of 2,775,792 births from January 2006 to December 2019. The proportion of advanced maternal age (AMA) pregnancies increased from 11.63% in 2006 to 30.94% in 2019. Overall, invasive diagnostic testing was used in 87.22% of AMA pregnancies. The prenatal detection rate of trisomy 21 and 18 increased from 74.1% and 83.3% in 2006 to 96.9% and 98.8% in 2019, respectively. Conclusion: During the second-trimester and cFTS periods, the percentage of AMA pregnancies increased every year and the number of invasive procedures also accompany with increased percentage of AMA. However, during the period that NIPT were implemented, the percentage of invasive procedures decreased.
- Open Access
- 16 August 2018
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 57 (4) , 551-554
Trisomy 21 screening based on first and second trimester in a Taiwanese population
- 16 August 2018
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 57 (4) , 551-554
Open AccessTrisomy 21 screening based on first and second trimester in a Taiwanese population